AkiCept commercializes an intravascular treatment procedure for acute kidney injury.
AkiCept has raised $265K in total funding. The most recent round was Seed. The last funding was announced in November 2023.
AkiCept is headquartered in Carmel, United States.
AkiCept commercializes an intravascular treatment procedure for acute kidney injury.
AkiCept is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AkiCept — Funding & Investors." VCBacked, November 27, 2023, https://www.vcbacked.co/company/akicept. Accessed August 17, 2026.
VCBacked. (2023). AkiCept — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/akicept
{{cite web |title=AkiCept — Funding & Investors |url=https://www.vcbacked.co/company/akicept |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated